Bristol-Myers Squibb Company et al v. TAHO Pharmaceuticals Limited
| Bristol-Myers Squibb Company and Pfizer Inc. |
| TAHO Pharmaceuticals Limited |
| 1:2026cv01374 |
| October 23, 2026 |
| U.S. District Court for the District of Delaware |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
This docket was last retrieved on October 23, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 6 Summons Issued as to TAHO Pharmaceuticals Limited on 10/26/2026. (jfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed - filed by Bristol-Myers Squibb Company, Pfizer Inc. (jfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,326,945 B2. (jfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/09/2026. Date of Expiration of Patent: 08/24/2031.Thirty Month Stay Deadline: 3/9/2029. (jfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
| Filing 1 COMPLAINT against TAHO Pharmaceuticals Limited (Filing fee $ 405, receipt number ADEDC-5097130) - filed by Pfizer Inc., Bristol-Myers Squibb Company. (Attachments: #1 Exhibits A-D, #2 Civil Cover Sheet)(jfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.